---
title: Natural history of HPV16-E6 serology among cancer-free men in a multicenter
  longitudinal cohort study
date: '2024-12-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39658222/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241211171330&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: HPV16-E6 seropositivity is rare but generally stable once
  detected; thus, HPV16-E6 antibodies may be an informative biomarker of HPV-driven
  OPSCC. Few men seroreverted following HPV16-E6 seropositivity but remained close
  to the seropositivity cut-off; thus, cancer risk among these men is less ...'
disable_comments: true
---
CONCLUSION: HPV16-E6 seropositivity is rare but generally stable once detected; thus, HPV16-E6 antibodies may be an informative biomarker of HPV-driven OPSCC. Few men seroreverted following HPV16-E6 seropositivity but remained close to the seropositivity cut-off; thus, cancer risk among these men is less ...